| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8769725 | American Journal of Kidney Diseases | 2018 | 9 Pages |
Abstract
Pulmonary hypertension is associated with a substantially increased risk for death and cardiovascular events in patients with CKD and ESRD. Risk is higher in patients with ESRD receiving dialysis compared with patients with CKD stages 1 to 5. Understanding the effect of interventions to lower pulmonary artery pressure on the survival of these patents awaits their evaluation in randomized controlled trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Mengyao Tang, Jonathan A. Batty, Chiayu Lin, Xiaohong Fan, Kevin E. Chan, Sahir Kalim,